about
PolyPid Ltd is a clinical-stage biopharmaceutical company engaged in the research and development of products based on PLEX (Polymer-Lipid Encapsulation MatriX), the company's proprietary drug delivery technology. PLEX is capable of encapsulating man...
Read More
3.79
-0.04
(-1.04%)
95,350
XNAS Volume
XNAS 03 Nov, 2025 4:30 PM (EST)
Board Meeting
The next board meeting for Polypid Ltd is on 13 Nov 2025 for the purpose of PolyPid Ltd Third Quarter Earnings Results for 2025
See details
Not Eligible
Expensive Valuation
Technically Moderately Bullish
Polypid Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..